Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical TrialGlobeNewsWire • 04/03/23
Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/09/23
Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) TrialGlobeNewsWire • 03/08/23
Alpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver MetastasesGlobeNewsWire • 03/01/23
Alpha Tau to Participate in Citi's 2023 Healthcare Services, Medtech, Tools & HCIT ConferenceGlobeNewsWire • 02/21/23
Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023GlobeNewsWire • 12/13/22
Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/22/22
Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation OncologyGlobeNewsWire • 10/21/22
OurCrowd Launches $200 Million Global Health Equity Fund in collaboration with the WHO Foundation at the Clinton Global InitiativeBusiness Wire • 09/19/22
Alpha Tau Announces the Acceptance in Major Peer-Reviewed Journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of Two Landmark Pre-Clinical Studies Demonstrating Significant Potential Synergies Between the AlGlobeNewsWire • 09/08/22
Alpha Tau Medical Announces Second Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/25/22
Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment PlanningGlobeNewsWire • 08/22/22
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCCPRNewsWire • 06/08/22
Alpha Tau Medical Announces First Quarter 2022 Financial Results and Provides Corporate UpdatePRNewsWire • 05/26/22
First Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer TrialPRNewsWire • 05/23/22